Literature DB >> 28407410

Variable clinical course of identical twin neonates with Alström syndrome presenting coincidentally with dilated cardiomyopathy.

Seth A Hollander1, Norah Alsaleh2, Maura Ruzhnikov2, Kristen Jensen3, David N Rosenthal1, David A Stevenson2, Melanie Manning2.   

Abstract

Alström Syndrome (AS) is a rare autosomal recessive disorder caused by mutations in the ALMS1 gene. We report monozygotic twin infants who presented concurrently with symptoms of congestive heart failure (CHF) due to dilated cardiomyopathy (DCM). Following their initial presentation, one twin improved both echocardiographically and functionally while the other twin showed a progressive decline in ventricular function and worsening CHF symptoms requiring multiple hospitalizations and augmentation of heart failure therapy. Concordant findings of nystagmus, vision loss, and developmental delay were noted in both twins. Additional discordant findings included obesity and signs of insulin resistance in one twin. Genetic testing on one sibling confirmed AS. These twins underscore the importance of considering AS in any child presenting with DCM, particularly in infancy, and highlights that, even in monozygotic twins, the clinical course of AS is variable with regard to both the cardiac and non-cardiac manifestations of the disease.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  alstrom; cardiomyopathy; heart failure; symptoms

Mesh:

Substances:

Year:  2017        PMID: 28407410     DOI: 10.1002/ajmg.a.38200

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  2 in total

1.  A Rare Case of Severe Dilated Cardiomyopathy in Early Infancy.

Authors:  Meike Schwendt; Johannes Kroll; Thilo Fleck; Brigitte Stiller
Journal:  Thorac Cardiovasc Surg Rep       Date:  2021-01-20

Review 2.  Mutation identification and prediction for severe cardiomyopathy in Alström syndrome, and review of the literature for cardiomyopathy.

Authors:  Savas Dedeoglu; Elif Dede; Funda Oztunc; Asuman Gedikbasi; Gozde Yesil; Reyhan Dedeoglu
Journal:  Orphanet J Rare Dis       Date:  2022-09-15       Impact factor: 4.303

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.